{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:03:07Z","timestamp":1789646587318,"version":"4.0.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,17]]},"DOI":"10.7759\/cureus.116414","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:27:44Z","timestamp":1789644464000},"source":"Crossref","is-referenced-by-count":0,"title":["Acute Psychosis and Dissociative Syndrome Following Binge Recreational Nitrous Oxide Use: A Case Report"],"prefix":"10.7759","author":[{"given":"Francisco","family":"Agostinho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Moutinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina K","family":"C\u00e2mara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Beatriz","family":"Resende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(24)00298-6","article-title":"Tackling the growing burden of nitrous oxide-induced public health harms","volume":"10","author":"Zaloum SA","year":"2025","unstructured":"Zaloum SA, Mair D, Paris A, Smith LJ, Patyjewicz M, Onen BL, Noyce AJ. Tackling the growing burden of nitrous oxide-induced public health harms. Lancet Public Health. 2025, 10:e257-63. 10.1016\/S2468-2667(24)00298-6","journal-title":"Lancet Public Health"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2810\/2003","article-title":"Recreational Use of Nitrous Oxide: A Growing Concern for Europe","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2022","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. Recreational Use of Nitrous Oxide: A Growing Concern for Europe. Publications Office of the European Union, Luxembourg City, Luxembourg; 2022. 10.2810\/2003"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12372","article-title":"Neurologic, psychiatric, and other medical manifestations of nitrous oxide abuse: a systematic review of the case literature","volume":"25","author":"Garakani A","year":"2016","unstructured":"Garakani A, Jaffe RJ, Savla D, Welch AK, Protin CA, Bryson EO, McDowell DM. Neurologic, psychiatric, and other medical manifestations of nitrous oxide abuse: a systematic review of the case literature. Am J Addict. 2016, 25:358-69. 10.1111\/ajad.12372","journal-title":"Am J Addict"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1192\/bja.2019.57","article-title":"Just say N2O - nitrous oxide misuse: essential information for psychiatrists","volume":"26","author":"Sheldon RJG","year":"2020","unstructured":"Sheldon RJG, Reid M, Schon F, Poole NA. Just say N2O - nitrous oxide misuse: essential information for psychiatrists. BJPsych Adv. 2020, 26:72-81. 10.1192\/bja.2019.57","journal-title":"BJPsych Adv"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2021.1938107","article-title":"Does vitamin B12 deficiency explain psychiatric symptoms in recreational nitrous oxide users? A narrative review","volume":"59","author":"Paulus MC","year":"2021","unstructured":"Paulus MC, Wijnhoven AM, Maessen GC, Blankensteijn SR, van der Heyden MA. Does vitamin B12 deficiency explain psychiatric symptoms in recreational nitrous oxide users? A narrative review. Clin Toxicol (Phila). 2021, 59:947-55. 10.1080\/15563650.2021.1938107","journal-title":"Clin Toxicol (Phila)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.25.1394","article-title":"Psychosis related to nitrous oxide misuse: a case series and systematic review","volume":"24","author":"Garriga-Sol\u00e9 L","year":"2026","unstructured":"Garriga-Sol\u00e9 L, Ortega-Hern\u00e1ndez G, Acosta-Villalobos XA, Grau-L\u00f3pez L, Ramos-Quiroga JA, Palma-\u00c1lvarez RF. Psychosis related to nitrous oxide misuse: a case series and systematic review. Clin Psychopharmacol Neurosci. 2026, 24:252-76. 10.9758\/cpn.25.1394","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00303","article-title":"Severe sleep deprivation causes hallucinations and a gradual progression toward psychosis with increasing time awake","volume":"9","author":"Waters F","year":"2018","unstructured":"Waters F, Chiu V, Atkinson A, Blom JD. Severe sleep deprivation causes hallucinations and a gradual progression toward psychosis with increasing time awake. Front Psychiatry. 2018, 9:303. 10.3389\/fpsyt.2018.00303","journal-title":"Front Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus F","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, et al.. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016, 15:391-404. 10.1016\/S1474-4422(15)00401-9","journal-title":"Lancet Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000059383","article-title":"Ecstasy-induced psychotic disorder: six-month follow-up study","volume":"8","author":"Landabaso MA","year":"2002","unstructured":"Landabaso MA, Iraurgi I, Jim\u00e9nez-Lerma JM, Calle R, Sanz J, Guti\u00e9rrez-Fraile M. Ecstasy-induced psychotic disorder: six-month follow-up study. Eur Addict Res. 2002, 8:133-40. 10.1159\/000059383","journal-title":"Eur Addict Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.694863","article-title":"Substance-induced psychoses: an updated literature review","volume":"12","author":"Fiorentini A","year":"2021","unstructured":"Fiorentini A, Cant\u00f9 F, Crisanti C, Cereda G, Oldani L, Brambilla P. Substance-induced psychoses: an updated literature review. Front Psychiatry. 2021, 12:694863. 10.3389\/fpsyt.2021.694863","journal-title":"Front Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2022-0516","article-title":"Nitrous oxide misuse: a clue not to be missed in young patients with venous thromboembolism","volume":"23","author":"Er C","year":"2023","unstructured":"Er C, Breen K, Cohen AT. Nitrous oxide misuse: a clue not to be missed in young patients with venous thromboembolism. Clin Med (Lond). 2023, 23:170-2. 10.7861\/clinmed.2022-0516","journal-title":"Clin Med (Lond)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.41428","article-title":"Nitrous oxide-induced cerebral venous thrombosis: a case report, potential mechanisms, and literature review","volume":"15","author":"Banjongjit A","year":"2023","unstructured":"Banjongjit A, Sutamnartpong P, Mahanupap P, Phanachet P, Thanakitcharu S. Nitrous oxide-induced cerebral venous thrombosis: a case report, potential mechanisms, and literature review. Cureus. 2023, 15:e41428. 10.7759\/cureus.41428","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci4010073","article-title":"The neurotoxicity of nitrous oxide: the facts and \"putative\" mechanisms","volume":"4","author":"Savage S","year":"2014","unstructured":"Savage S, Ma D. The neurotoxicity of nitrous oxide: the facts and \"putative\" mechanisms. Brain Sci. 2014, 4:73-90. 10.3390\/brainsci4010073","journal-title":"Brain Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/nm0498-460","article-title":"Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin","volume":"4","author":"Jevtovi\u0107-Todorovi\u0107 V","year":"1998","unstructured":"Jevtovi\u0107-Todorovi\u0107 V, Todorovi\u0107 SM, Mennerick S, et al.. Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat Med. 1998, 4:460-3. 10.1038\/nm0498-460","journal-title":"Nat Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-022-06121-9","article-title":"Pharmacological modelling of dissociation and psychosis: an evaluation of the Clinician Administered Dissociative States Scale and Psychotomimetic States Inventory during nitrous oxide ('laughing gas')-induced anomalous states","volume":"239","author":"Piazza GG","year":"2022","unstructured":"Piazza GG, Iskandar G, Hennessy V, et al.. Pharmacological modelling of dissociation and psychosis: an evaluation of the Clinician Administered Dissociative States Scale and Psychotomimetic States Inventory during nitrous oxide ('laughing gas')-induced anomalous states. Psychopharmacology (Berl). 2022, 239:2317-29. 10.1007\/s00213-022-06121-9","journal-title":"Psychopharmacology (Berl)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/20451253211072341","article-title":"Clozapine- and non-clozapine-associated neutropenia in patients with schizophrenia: a retrospective cohort study","volume":"12","author":"Johannsen CF","year":"2022","unstructured":"Johannsen CF, Petersen TS, Nielsen J, J\u00f8rgensen A, Jimenez-Solem E, Fink-Jensen A. Clozapine- and non-clozapine-associated neutropenia in patients with schizophrenia: a retrospective cohort study. Ther Adv Psychopharmacol. 2022, 12:10.1177\/20451253211072341","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/3980872","article-title":"Risperidone-induced neutropenia in a schizophrenic patient: a case report and literature review","volume":"2021","author":"Atolagbe A","year":"2021","unstructured":"Atolagbe A, Nkemjika S, Popoola O, Oladeji O, Kogan I, Saeed H, Olupona T. Risperidone-induced neutropenia in a schizophrenic patient: a case report and literature review. Case Rep Psychiatry. 2021, 2021:3980872. 10.1155\/2021\/3980872","journal-title":"Case Rep Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-42078-x","article-title":"Rapid decline of elevated homocysteine level in nitrous oxide use","volume":"16","author":"Dawudi Y","year":"2026","unstructured":"Dawudi Y, Gendre T, Bonnan M. Rapid decline of elevated homocysteine level in nitrous oxide use. Sci Rep. 2026, 16:12152. 10.1038\/s41598-026-42078-x","journal-title":"Sci Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/526857-acute-psychosis-and-dissociative-syndrome-following-binge-recreational-nitrous-oxide-use-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:27:45Z","timestamp":1789644465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/526857-acute-psychosis-and-dissociative-syndrome-following-binge-recreational-nitrous-oxide-use-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.116414","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,17]]}}}